NYSE:ISR

Isoray (ISR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.28
$0.42
52-Week Range
N/A
Volume
145,000 shs
Average Volume
290,697 shs
Market Capitalization
$54.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ISR stock logo

About Isoray Stock (NYSE:ISR)

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

ISR Stock News Headlines

French ISR Label Revamp Report
Why IsoRay (ISR) Is Plunging Today
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Why IsoRay (ISR) Stock Is Surging Today
IsoRay (ISR) Reports Q2 Loss, Misses Revenue Estimates
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Isoray, Inc. (ISR) Q1 2023 Earnings Call Transcript
See More Headlines
Receive ISR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Isoray and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
4/24/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-7,270,000.00
Net Margins
-115.91%
Pretax Margin
-91.45%

Debt

Sales & Book Value

Annual Sales
$10.80 million
Book Value
$0.43 per share

Miscellaneous

Free Float
138,674,000
Market Cap
$54.57 million
Optionable
Not Optionable
Beta
1.48
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Lori A. Woods
    Chief Executive Officer & Director
  • Jennifer Streeter
    Chief Operating Officer & VP-Human Resources
  • Mark J. Austin
    Co-CFO, Secretary & Chief Accounting Officer
  • Jonathan R. Hunt
    CFO & Principal Financial Officer
  • William A. Cavanagh
    Chief Research & Development Officer

ISR Stock Analysis - Frequently Asked Questions

How were Isoray's earnings last quarter?

Isoray, Inc. (NYSE:ISR) issued its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The firm earned $2.56 million during the quarter, compared to analysts' expectations of $2.58 million. Isoray had a negative trailing twelve-month return on equity of 17.12% and a negative net margin of 115.91%.

This page (NYSE:ISR) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners